News & Events

• September 19, 2019
  

  Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases

  Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.

• August 7, 2019
  

  Funded by FDA, C-Path and NORD to Launch Rare Disease Data and Analytics Platform

  C-Path and NORD Rare Disease Cures Accelerator Data Analytics Platform Launch, Tuesday, Sept. 17, Bethesda, MD

  C-Path and the National Organization for Rare Disorders® will host a meeting to formally launch development of a new rare disease data and analytics platform. Funded by a cooperative agreement through the U.S. Food and Drug Administration, the goal of the platform is to accelerate the movement of therapies from bench to bedside for rare diseases. Register here.